Shoshana Shendelman, PhD: Dr. Shendelman is a partner and Managing Director at Clearpoint Strategy Group, a boutique strategic advisory firm based out of New York City. At Clearpoint, Dr. Shendelman leads the Neurology/CNS team, developing product and franchise strategies, evaluating novel product candidates for partnering/acquisition, and shaping client focus within the neurology space. Dr. Shendelman’s tenure in consulting has spanned a wide range of clients, including top 10 pharmaceutical companies, biotech start-ups, and VC firms. Dr. Shendelman received her doctorate from Columbia University in Cellular, Molecular, and Biophysical Studies (CMBS), where her graduate work focused on neuronal stem cell differentiation and molecular mechanisms of Parkinson Disease.